N. Boku

Randomized Controlled Trial Comparing Gastrectomy Plus Chemotherapy with Chemotherapy Alone in Advanced Gastric Cancer with A Single Non-curable Factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01

Kazumasa Fujitani, Han‐Kwang Yang, Yukinori Kurokawa et al. · Japanese Journal of Clinical Oncology · 2008 · 63 citations · Full text

Single Non-curable Factor, Adverse Events, Surgical Oncology +13

Three hundred and thirty-three experiences with the bidirectional Glenn procedure in a single institute

Yoshihisa Tanoue, Hideaki Kado, N. Boku et al. · Interactive Cardiovascular and Thoracic Surgery · 2006 · 41 citations · Full text

A Phase II Study of Irinotecan in Combination with 120-h Infusion of 5-Fluorouracil in Patients with Metastatic Colorectal Carcinoma: Japan Clinical Oncology Group Study (JCOG9703)

Atsushi Ohtsu, N. Boku, T. Yoshioka et al. · Japanese Journal of Clinical Oncology · 2003 · 16 citations · Full text

Randomized phase III study of 5-fluorouracil continuous infusion (5FUci) versus methotrexate and 5-FU sequential therapy (MF) in gastric cancer with peritoneal metastasis (JCOG0106)

Kuniaki Shirao, N. Boku, Yasuhide Yamada et al. · Journal of Clinical Oncology · 2009 · 16 citations

Surgical Oncology, Gastrointestinal Pharmacology, Gastroenterology +17

Randomized phase II study of best-available 5-fluorouracil (5-FU) versus weekly paclitaxel in gastric cancer (GC) with peritoneal metastasis (PM) refractory to 5-FU-containing regimens (JCOG0407).

Hiroya Takiuchi, Haruyuki Fukuda, N. Boku et al. · Journal of Clinical Oncology · 2010 · 15 citations

Cancer Management, Gastroenterology, Phase Ii Study +17